Recent Posts
- EpiVax and CUBRC Awarded FDA Contract Worth $2M for Development of Control Peptides for Immunogenicity Risk Assessment Assays Supporting Regulatory Filings of Generic Peptide Drugs
- Thinking Out Loud: September 2024
- The Amsterdam Immunogenicity and Tolerance Seminar: 2024
- The Computational Vaccinology Symposium: 2024
- The Westin Immunogenicity Seminar: 2024
Recent Comments
No comments to show.